Li et al.22 reported that in an inflammatory microenvironment induced by lipopolysaccharide (LPS), STEAP4 silencing in prostate cancer cells activates the cGMP-PKG pathway, reducing cell proliferation. Here, STEAP4 is linked to prostate carcinoma.